Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00384462 · ClinicalTrials.gov registry record
Study to Evaluate the Incidence of Hospitalizations and Respiratory Tract Infections in Premature Infants
A clinical trial, sponsored by MedImmune.
- Completed
- Registry status
- 346
- Enrollment target
NCT00384462 is a clinical trial that has completed, run by MedImmune. The registered enrollment target is 346 participants.
The verdict
NCT00384462 has completed, sponsored by MedImmune.
- COMPLETED
- Registry status
- 346 participants
- Enrollment target
Study Summary
The purpose of this study is to describe respiratory syncytial virus (RSV) hospitalization rates and to begin to address the utilization of outpatient resources for RSV medically-attended lower respiratory tract infections (MALRI) in 32-35 week gestational age (GA) premature infants who are less than 6 months of age and do not receive treatment.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 346 participants |
| Start Date | 2006-10 |
| Est. Completion | 2008-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00384462
The ClinicalTrials.gov registry entry for NCT00384462 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 346 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is MedImmune, which has 210 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00384462 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00384462 about?
NCT00384462 is a clinical study titled "Study to Evaluate the Incidence of Hospitalizations and Respiratory Tract Infections in Premature Infants". The purpose of this study is to describe respiratory syncytial virus (RSV) hospitalization rates and to begin to address the utilization of outpatient resources for RSV medically-attended lower respiratory tract infections (MALRI) in 32-35 week gestational age (GA) premature infants who are less tha...
What is the current status of trial NCT00384462?
This trial is currently completed. The enrollment target is 346 participants. The study started on 2006-10. Estimated completion is 2008-01.
Who is sponsoring clinical trial NCT00384462?
This trial is sponsored by MedImmune, which has 210 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.